Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 130

1.

The combined depletion of monoamines alters the effectiveness of subthalamic deep brain stimulation.

Faggiani E, Delaville C, Benazzouz A.

Neurobiol Dis. 2015 Oct;82:342-8. doi: 10.1016/j.nbd.2015.07.010. Epub 2015 Jul 20.

PMID:
26206409
2.

The impact of emotional distress on motor blocks and festination in Parkinson's disease.

Starkstein S, Dragovic M, Brockman S, Wilson M, Bruno V, Merello M.

J Neuropsychiatry Clin Neurosci. 2015;27(2):121-6. doi: 10.1176/appi.neuropsych.13030053.

PMID:
25923851
3.

Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease.

Weintraub D, Simuni T, Caspell-Garcia C, Coffey C, Lasch S, Siderowf A, Aarsland D, Barone P, Burn D, Chahine LM, Eberling J, Espay AJ, Foster ED, Leverenz JB, Litvan I, Richard I, Troyer MD, Hawkins KA; Parkinson's Progression Markers Initiative.

Mov Disord. 2015 Jun;30(7):919-27. doi: 10.1002/mds.26170. Epub 2015 Mar 4.

4.

Evidence of improved immediate verbal memory and diminished category fluency following STN-DBS in Chinese-Cantonese patients with idiopathic Parkinson's disease.

Tang V, Zhu CX, Chan D, Lau C, Chan A, Mok V, Yeung J, Poon WS.

Neurol Sci. 2015 Aug;36(8):1371-7. doi: 10.1007/s10072-015-2117-1. Epub 2015 Feb 24.

PMID:
25708249
5.

Mental health diagnoses and health care utilization in persons with dementia, Parkinson's disease, and stroke.

Calleo J, Amspoker AB, Marsh L, Kunik ME.

J Neuropsychiatry Clin Neurosci. 2015;27(2):e117-21. doi: 10.1176/appi.neuropsych.13110333. Epub 2014 Dec 26.

PMID:
25541867
6.

Sociodemographic, neuropsychiatric and cognitive characteristics of pathological gambling and impulse control disorders NOS in Parkinson's disease.

Pontieri FE, Assogna F, Pellicano C, Cacciari C, Pannunzi S, Morrone A, Danese E, Caltagirone C, Spalletta G.

Eur Neuropsychopharmacol. 2015 Jan;25(1):69-76. doi: 10.1016/j.euroneuro.2014.11.006. Epub 2014 Nov 18.

PMID:
25435085
7.

Cognitive dysfunction in Parkinson's disease related to the R1441G mutation in LRRK2.

Estanga A, Rodriguez-Oroz MC, Ruiz-Martinez J, Barandiaran M, Gorostidi A, Bergareche A, Mondragon E, Lopez de Munain A, Marti-Masso JF.

Parkinsonism Relat Disord. 2014 Oct;20(10):1097-100. doi: 10.1016/j.parkreldis.2014.07.005. Epub 2014 Jul 30.

PMID:
25127457
8.

Systematic review of factors associated with depression and anxiety disorders among older adults with Parkinson's disease.

Sagna A, Gallo JJ, Pontone GM.

Parkinsonism Relat Disord. 2014 Jul;20(7):708-15. doi: 10.1016/j.parkreldis.2014.03.020. Epub 2014 Apr 1. Review.

9.

Progressive neuropsychiatric manifestations of phenylketonuria in adulthood.

Daelman L, Sedel F, Tourbah A.

Rev Neurol (Paris). 2014 Apr;170(4):280-7. doi: 10.1016/j.neurol.2013.09.012. Epub 2014 Apr 13.

PMID:
24726436
10.

[Coexistent depressive and anxiety disorders in neurological diseases: from a perspective of multimorbidity].

Kapfhammer HP.

Nervenarzt. 2014 Apr;85(4):437-44. doi: 10.1007/s00115-013-3936-z. German.

PMID:
24619147
11.

Brazilian Medical Association guidelines for the diagnosis and differential diagnosis of panic disorder.

Levitan MN, Chagas MH, Linares IM, Crippa JA, Terra MB, Giglio AT, Cordeiro JL, Garcia GJ, Hasan R, Andrada NC, Nardi AE.

Rev Bras Psiquiatr. 2013 Oct-Dec;35(4):406-15. doi: 10.1590/1516-4446-2012-0860. Epub 2013 Dec 23. Review.

12.

Application of depression rating scales in patients with Parkinson's disease with and without co-Occurring anxiety.

Calleo J, Williams JR, Amspoker AB, Swearingen L, Hirsch ES, Anderson K, Goldstein SR, Grill S, Lehmann S, Little JT, Margolis RL, Palanci J, Pontone GM, Weiss H, Rabins P, Marsh L.

J Parkinsons Dis. 2013;3(4):603-8. doi: 10.3233/JPD-130264.

PMID:
24275604
13.

Anxiety has specific syndromal profiles in Parkinson disease: a data-driven approach.

Starkstein SE, Dragovic M, Dujardin K, Marsh L, Martinez-Martin P, Pontone GM, Richard IH, Weintraub D, Leentjens AF.

Am J Geriatr Psychiatry. 2014 Dec;22(12):1410-7. doi: 10.1016/j.jagp.2013.09.006. Epub 2013 Nov 5.

PMID:
24200594
14.

Deep brain stimulation (DBS) at the interface of neurology and psychiatry.

Williams NR, Okun MS.

J Clin Invest. 2013 Nov;123(11):4546-56. doi: 10.1172/JCI68341. Epub 2013 Nov 1. Review.

15.

[Non-motor symptoms in Parkinson's disease: cognition and behavior].

Bonnet AM, Czernecki V.

Geriatr Psychol Neuropsychiatr Vieil. 2013 Sep;11(3):295-304. doi: 10.1684/pnv.2013.0423. Review. French.

PMID:
24026132
16.

Pharmacologic treatment of anxiety disorders in Parkinson disease.

Pontone GM, Williams JR, Anderson KE, Chase G, Goldstein SR, Grill S, Hirsch ES, Lehmann S, Little JT, Margolis RL, Palanci J, Rabins PV, Weiss HD, Marsh L.

Am J Geriatr Psychiatry. 2013 Jun;21(6):520-8. doi: 10.1016/j.jagp.2012.10.023. Epub 2013 Mar 29.

17.

[Deep brain stimulation. Twenty-five years later].

Gelabert-González M, Relova Quinteiro JL, Castro-García A.

Med Clin (Barc). 2013 Jul 7;141(1):29-32. doi: 10.1016/j.medcli.2013.01.038. Epub 2013 Mar 26. Review. Spanish. No abstract available.

PMID:
23540386
18.

Obsessive compulsive personality disorder and Parkinson's disease.

Nicoletti A, Luca A, Raciti L, Contrafatto D, Bruno E, Dibilio V, Sciacca G, Mostile G, Petralia A, Zappia M.

PLoS One. 2013;8(1):e54822. doi: 10.1371/journal.pone.0054822. Epub 2013 Jan 24.

19.

Hedonic tone and its mood and cognitive correlates in Parkinson's disease.

Spalletta G, Fagioli S, Meco G, Pierantozzi M, Stefani A, Pisani V, Caltagirone C, Pontieri FE, Assogna F.

Depress Anxiety. 2013 Jan;30(1):85-91. doi: 10.1002/da.22036.

PMID:
23300113
20.

Anxiety disorders, physical illnesses, and health care utilization in older male veterans with Parkinson disease and comorbid depression.

Qureshi SU, Amspoker AB, Calleo JS, Kunik ME, Marsh L.

J Geriatr Psychiatry Neurol. 2012 Dec;25(4):233-9. doi: 10.1177/0891988712466458. Epub 2012 Nov 29.

PMID:
23197499
Items per page

Supplemental Content

Loading ...
Write to the Help Desk